Numenos.ai

Restructuring humanity's approach to Cancer Treatment from first principles.

Numenos was founded on the insight that biology lacks the foundational laws that make physics predictive, and we lack the tools to discover them.

Medicine today treats diseases as separate, isolated problems. Cancer researchers study cancer. Autoimmune specialists study autoimmune disease. Neurologists study neurological conditions. Each operates in its own silo, learning correlations specific to their disease without discovering the deeper principles that connect them all. This lack of understanding is the root cause of our inability to provide much-needed solutions to patients.

Our breakthrough came from asking a different question: What if diseases aren't separate entities but different manifestations of universal biological principles under different contexts? What if there are laws governing human biology—like the laws of physics—that operate across all conditions?

At Numenos, we assembled a unique team crossing defense industry and translational biology to build patient-centric biological world models that learn from individual patient data across all diseases simultaneously. Instead of finding patterns specific to lung cancer or kidney disease, our platform discovers the invariant causal mechanisms that underlie all human biology. We're learning the rules themselves, not memorizing outcomes.

Our vision is that machine learning is biology's recombinant DNA moment. Now is the time to develop solutions that deliver individualized treatments, because patients don't have time for trial and error.

They deserve better. And they will get better.